Gecina Nom (GI6A) 시세

Glad my concern did not prove to be true.
GLTA

Lionsgate has never verified and/or confirmed the "deal." with SAPX.

There isn't even a quote from anybody from Lionsgate confirming the deal in the press release like all press releases have when confirming a deal between two companies.

The Lionsgate deal also doesn't

I call like I see them, crybaby. 

Source of funding, I would say.

Thank you!!!!

Also, part of this may be simply that's it's a big Government with a lot of fish to fry.

Nats

$20pps by last December!

ORGANICALLY....

HAHAHAHHAA
#FOS

good morning Harley!

and Skeeter

Are you disagreeing with my statement that the so ck marjlekmas how this stock was going to be a winner. Well genius, this POS is in triple zeros with horrible volume, zippoo subsntativ eaccomplishments fro the mananagmene tteam and zeros in the revenuel colmumn of the [ast, 11 quarterly reports You

so FSR today?

Pfizer reports Q4 adjusted EPS 63c, consensus 46c
Reports Q4 revenue $17.8B, consensus $17.26B. Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: "2024 was a strong year of execution and performance for Pfizer in which we met or exceeded our strategic and financial commitments,

Merck to temporarily pause shipments of Gardasil into China
Merck anticipates full-year 2025 sales to be between $64.1B-$65.6B, including a negative impact of foreign exchange of approximately 2% at mid-January 2025 exchange rates. "This sales range reflects a decision to temporarily pause sh

https://scontent-lga3-2.xx.fbcdn.net/v/t39.30808-6/476493445_919481470345910_6224940449202659042_n.jpg?stp=dst-jpg_p526x296_tt6&_nc_cat=105&ccb=1-7&_nc_sid=833d8c&_nc_ohc=d2sGJx0i5iMQ7kNvgEF3BeS&_nc_zt=23&_nc_ht=scontent-lga3-2.xx&_nc_gid=ABL2Mz_c1XKrIzonDXEpHC8&oh=00_AYA3QfkLoO_nE42x-CuveWSeeRq8o-i

Come on people! It fell way more than it's worth it!

ENR
Energizer reports Q1 adjusted EPS 67c, consensus 65c
Reports Q1 revenue $731.7M, consensus $726.23M. "We are very pleased to have started fiscal 2025 with a strong top and bottom line performance as we continued to execute our strategies successfully," said Mark LaVigne, CEO. "N

Jacobs narrows FY25 adjusted EPS view to $5.85-$6.20 from $5.80-$6.20
Consensus $6.01. Backs FY25 revenue growth view mid-to-high single digits. The company said, "The Company reiterates its fiscal 2025 outlook for adjusted net revenue to grow mid-to-high single digits over fiscal 2024, adjus

GRAB Grab jumps 8% to $4.89 after GoTo merger talks report, HSBC upgrade

Also, if he has news in his pocket, it's best not to post it today. We'll have enough momentum from coming off the expert market to move this thing probably over a penny. If he has news, he's better off releasing it tomorrow.

https://www.securitieslawyer101.com/2023/shell-hijacker-mark-miller-sentenced-to-one-year-in-prison/

Court documents show that Capitol Capital Corporation received several big chunks of stock in IGEX, then transferred the shares to Tiger Trout Capital LLC, a Puerto Rican entity contro

Record revenues only days away.

Locked $ Loaded


ELTP

Shaking my head in disgust at the FDA. The good doctor is making milestones in India with unprecedented cancer treatments. Phenomenal, now we are pushing for 90 patients in the next round. We should have been treating patients in the US for years now. The good doctors persistence will not let th

@VerifDEV
Team already paid for the take over of
@ZeusOfSolana
with
@dexscreener
, awaiting for the process to finalize so we can revive this beautiful project, hope to see you all at the markets celebrating.
@solana

@RaydiumProtocol

So typical.

The only investors who are defending VXIT have the biggest losses and are losing the most money in the shares of VXIT.

we have no other choice than to wait. I estimate that 75% of retail is underwater now.